Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?

Population: Populations living in dengue endemic countries
Intervention: Pre-vaccination screening to determine serostatus and then only vaccinate those found to be seropositive
Comparison(s): Introducing the vaccine based on population seroprevalence criteria without individual screening
Outcome: Symptomatic dengue of any severity (including hospitalizations due to dengue and severe dengue)